Imatinib Mesylate 500 mg | 99.73%
TargetMol
Imatinib mesylate is a tyrosine kinase receptor inhibitor with antineoplastic activity (IC50s: 0.6 μM, 0.1 μM and 0.1 μM for v-Abl, c-Kit and PDGFR, respectively).
More Information Supplier Page
Imatinib mesylate is a tyrosine kinase receptor inhibitor with antineoplastic activity (IC50s: 0.6 μM, 0.1 μM and 0.1 μM for v-Abl, c-Kit and PDGFR, respectively).
More Information Supplier Page
Imatinib mesylate is a tyrosine kinase receptor inhibitor with antineoplastic activity (IC50s: 0.6 μM, 0.1 μM and 0.1 μM for v-Abl, c-Kit and PDGFR, respectively).
More Information Supplier Page
Mestranol, a semisynthetic estrogen, is used as an estrogen receptor agonist and must be demethylated to be biologically active.
More Information Supplier Page
Daptomycin is a cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.
More Information Supplier Page
Daptomycin is a cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.
More Information Supplier Page
Debutylbupivacaine is the intermediate of ropivacaine hydrochloride and bupivacaine.
More Information Supplier Page
Debutylbupivacaine is the intermediate of ropivacaine hydrochloride and bupivacaine.
More Information Supplier Page